TY - JOUR
T1 - Exploring the Villalta scale to capture postthrombotic syndrome using alternative approaches
T2 - A subanalysis of the ATTRACT trial
AU - Pop, Cristina T.
AU - Gu, Chu Shu
AU - Vedantham, Suresh
AU - Galanaud, Jean Philippe
AU - Kahn, Susan R.
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Background: Clinical trials that evaluated interventions to prevent postthrombotic syndrome (PTS) used the Villalta scale (VS) to define PTS, but there is a lack of consistency in its use. Objectives: This study aimed to improve the ability to identify patients with clinically meaningful PTS after DVT in participants of the ATTRACT trial. Methods: We conducted a post hoc exploratory analysis of 691 patients from the ATTRACT study, a randomized trial evaluating the effectiveness of pharmacomechanical thrombolysis to prevent PTS in proximal deep vein thrombosis. We compared 8 VS approaches to classify patients with or without PTS in terms of their ability to discriminate between those with poorer vs better venous disease-specific quality of life (Venous Insufficiency Epidemiological and Economic Study Quality of Life [VEINES-QOL]) between 6- and 24-months follow-up. The difference in the average area under the fitted curve of VEINES-QOL scores between PTS and no PTS (ΔAUC¯) were compared among approaches. Results: For any PTS (a single VS score ≥5), approaches 1 to 3 had similar ΔAUC¯ (−21.2, −23.7, −22.0, respectively). Adjusting the VS for contralateral chronic venous insufficiency (CVI) or restricting to patients without baseline CVI (approaches 7 and 8) did not improve ΔAUC¯ (−13.6, −19.9, respectively; P >.01). For moderate-to-severe PTS (a single VS score ≥10), approaches 5 and 6 requiring 2 positive assessments had greater but not statistically significant ΔAUC¯ than approach 4, using one single positive assessment (−31.7, −31.0, −25.5, respectively; P >.01). Conclusion: A single VS score of ≥ 5 reliably distinguishes patients with clinically meaningful PTS as assessed by impact on QOL and is preferred because of greater convenience (only one assessment needed). Alternative methods to define PTS (ie, adjusting for CVI) do not improve the scale's ability to identify clinically meaningful PTS.
AB - Background: Clinical trials that evaluated interventions to prevent postthrombotic syndrome (PTS) used the Villalta scale (VS) to define PTS, but there is a lack of consistency in its use. Objectives: This study aimed to improve the ability to identify patients with clinically meaningful PTS after DVT in participants of the ATTRACT trial. Methods: We conducted a post hoc exploratory analysis of 691 patients from the ATTRACT study, a randomized trial evaluating the effectiveness of pharmacomechanical thrombolysis to prevent PTS in proximal deep vein thrombosis. We compared 8 VS approaches to classify patients with or without PTS in terms of their ability to discriminate between those with poorer vs better venous disease-specific quality of life (Venous Insufficiency Epidemiological and Economic Study Quality of Life [VEINES-QOL]) between 6- and 24-months follow-up. The difference in the average area under the fitted curve of VEINES-QOL scores between PTS and no PTS (ΔAUC¯) were compared among approaches. Results: For any PTS (a single VS score ≥5), approaches 1 to 3 had similar ΔAUC¯ (−21.2, −23.7, −22.0, respectively). Adjusting the VS for contralateral chronic venous insufficiency (CVI) or restricting to patients without baseline CVI (approaches 7 and 8) did not improve ΔAUC¯ (−13.6, −19.9, respectively; P >.01). For moderate-to-severe PTS (a single VS score ≥10), approaches 5 and 6 requiring 2 positive assessments had greater but not statistically significant ΔAUC¯ than approach 4, using one single positive assessment (−31.7, −31.0, −25.5, respectively; P >.01). Conclusion: A single VS score of ≥ 5 reliably distinguishes patients with clinically meaningful PTS as assessed by impact on QOL and is preferred because of greater convenience (only one assessment needed). Alternative methods to define PTS (ie, adjusting for CVI) do not improve the scale's ability to identify clinically meaningful PTS.
KW - Villalta scale
KW - deep vein thrombosis
KW - diagnosis
KW - postthrombotic syndrome
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85149908929&partnerID=8YFLogxK
U2 - 10.1016/j.rpth.2022.100032
DO - 10.1016/j.rpth.2022.100032
M3 - Article
C2 - 36970743
AN - SCOPUS:85149908929
SN - 2475-0379
VL - 7
JO - Research and Practice in Thrombosis and Haemostasis
JF - Research and Practice in Thrombosis and Haemostasis
IS - 1
M1 - 100032
ER -